Achieve Life Sciences (ACHV) Total Liabilities (2010 - 2026)
Achieve Life Sciences' (ACHV) quarterly Total Liabilities came in at $22.4 million in Q1 2026, up 31.31% YoY from $17.1 million in Q1 2025, and up 10.63% on a QoQ basis from $20.3 million in Q4 2025.
Achieve Life Sciences (ACHV) Total Liabilities (2010 - 2026) Analysis & Trends
Achieve Life Sciences (ACHV) has 17 years of Total Liabilities data on file, last reported at $22.4 million in Q1 2026.
- Quarterly Total Liabilities rose 31.31% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.4 million (up 31.31% YoY) and the FY2025 annual result came in at $20.3 million, up 14.31% from the prior year.
- Total Liabilities grew to $22.4 million in Q1 2026, from $20.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $22.7 million in Q3 2022 to a low of $16.5 million in Q3 2024.
- A 5-year average of $19.9 million and a median of $20.3 million in 2023 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities soared 631.82% — and 2025, when it dropped 23.28%.
- Tracing ACHV's Total Liabilities over 5 years: stood at $21.7 million in 2022, then decreased by 3.92% to $20.8 million in 2023, then slipped by 14.82% to $17.7 million in 2024, then rose by 14.31% to $20.3 million in 2025, then climbed by 10.63% to $22.4 million in 2026.
- The last three Total Liabilities figures came in at $22.4 million (Q1 2026), $20.3 million (Q4 2025), and $18.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | 205.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 205.12 Mn |
| Mar 31, 2026 | 22.43 Mn |
| Dec 31, 2025 | 20.27 Mn |
| Sep 30, 2025 | 18.43 Mn |
| Jun 30, 2025 | 17.27 Mn |
| Mar 31, 2025 | 17.08 Mn |
| Dec 31, 2024 | 17.73 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Jun 30, 2024 | 22.51 Mn |
| Mar 31, 2024 | 20.57 Mn |
| Dec 31, 2023 | 20.82 Mn |
| Sep 30, 2023 | 20.30 Mn |
| Jun 30, 2023 | 19.22 Mn |
| Mar 31, 2023 | 20.36 Mn |
| Dec 31, 2022 | 21.67 Mn |
| Sep 30, 2022 | 22.68 Mn |
| Jun 30, 2022 | 20.82 Mn |
| Mar 31, 2022 | 19.18 Mn |
| Dec 31, 2021 | 19.47 Mn |
| Sep 30, 2021 | 3.10 Mn |